ISL
CMD

Ingalls & Snyder LLC’s Cantel Medical Corporation CMD Stock Holding History

Ingalls & Snyder LLC’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2,200
Closed -$203K – 451
2018
Q3 		$203K Hold
2,200
– – 0.01% 419
2018
Q2 		$216K Sell
2,200
-300
-12% -$33.6K 0.01% 369
2018
Q1 		$279K Hold
2,500
– – 0.01% 333
2017
Q4 		$257K Hold
2,500
– – 0.01% 346
2017
Q3 		$235K Buy
+2,500
New +$197K 0.01% 318
2017
Q2 		– Sell
-2,500
Closed -$200K – 416
2017
Q1 		$200K Sell
2,500
-1,250
-33% -$99.3K 0.01% 376
2016
Q4 		$295K Hold
3,750
– – 0.02% 321
2016
Q3 		$292K Hold
3,750
– – 0.02% 314
2016
Q2 		$258K Hold
3,750
– – 0.02% 349
2016
Q1 		$267K Hold
3,750
– – 0.02% 289
2015
Q4 		$233K Hold
3,750
– – 0.01% 323
2015
Q3 		$212K Hold
3,750
– – 0.01% 323
2015
Q2 		$201K Buy
+3,750
New +$182K 0.01% 347

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Ingalls & Snyder LLC's CMD Position: Q4 2018 in Review

Ingalls & Snyder LLC sold out of Cantel Medical Corporation (CMD) in Q4 2018, closing a stake of 2,200 shares — an estimated $203K sold.

Ingalls & Snyder LLC first reported a position in CMD in Q2 2015 and held it in 13 quarters. The position peaked at $295K in Q4 2016. 253 funds tracked by Wall St. Rank hold CMD as of Q4 2018.

  • Ingalls & Snyder LLC reported no remaining Cantel Medical Corporation position as of Q4 2018 after selling out during the quarter.
  • Ingalls & Snyder LLC sold 2,200 Cantel Medical Corporation shares in Q4 2018, an estimated $203K.
  • Ingalls & Snyder LLC first reported a position in Cantel Medical Corporation in Q2 2015 and held it in 13 quarters.
  • Ingalls & Snyder LLC's Cantel Medical Corporation position peaked at $295K in Q4 2016.
  • 253 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q4 2018.

Based on Ingalls & Snyder LLC's 13F filing for Q4 2018, filed 24 Jan 2019.